We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Noninflammatory disorders of female genital tract
This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.
Hormone replacement therapy (HRT) can be prescribed for menopause symptoms, as well as to prevent other longer-term problems that increase after the menopause, such as osteoporosis (thinner bones) and heart disease.
Although such women may benefit from HRT, our previous research showed that general practitioners (GPs) in more deprived areas prescribe less HRT to women than in other areas. Previous research has also shown that Black and South Asian women are less likely to be prescribed HRT. The reasons for this, and the extent to which
this relates to women’s expectations or how menopause care is organised and delivered is unknown.
We aim to understand this problem by carrying out:
1. Interviews and focus groups to explore with women, particularly from groups that are less often prescribed HRT (such as women from deprived areas and also Black and South Asian women) their experiences of obtaining information, care and support for the menopause and of menopause care in general practice. About forty women
will be recruited to take part in the study through GPs and through leaders of community groups.
2. Focus groups with healthcare professionals in general practice to explore the challenges to providing menopause care (particularly GPs working within populations that are ethnically diverse and deprived) and how these can be overcome.
The interviews and focus groups will be recorded, transcribed, and carefully analysed to identify key insights relevant to understanding women’s experiences and ways of improving the menopause care that is available to them.
The results will be shared through local community groups, social media channels, a webinar, published in journals and presented at conferences. We will also produce some advice and information for women about the menopause and treatment options; the form that this will take will be decided with the women involved in the
project, but could be an infographic, leaflet, or online sharable video.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Qualitative;
You can take part if:
You may not be able to take part if:
For women Exclusion criteria: with severe mental health or learning difficulties meaning that they cannot consent to take part with life limiting illness who have had a surgical menopause menopausal symptoms for > 3 years women with premature ovarian insufficiency
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by University of Warwick and funded by NIHR Central Commissioning Facility (CCF) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 56077
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
